Abstract
Background
Injecting drug users are at high risk of acquiring blood-borne infections. Ireland has had a harm reduction policy of methadone maintenance and needle exchange since 1992.
Aim
To estimate prevalence of hepatitis B, hepatitis C and HIV infection and appropriate uptake of hepatitis B vaccine in methadone attendees and to make recommendations for a simple record-based surveillance system.
Method
Retrospective study of 138 client records for evidence of laboratory tests or test results for blood-borne viruses and appropriate immunisation against hepatitis B.
Results
A total of 60% of clients had evidence of one or more laboratory tests in their notes. Of those tested for individual viruses, 5.1% were positive for hepatitis B surface antigen, 78.8% had antibodies to hepatitis C and 16.7% were HIV positive. Nearly two-thirds of clients had no evidence of vaccination or information on prior immunity in their records.
Conclusions
A standardised written protocol for screening for blood-borne viruses and for immunisation against hepatitis B in methadone service attendees was clearly needed, and was subsequently introduced by the Eastern Region Health Authority.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Madden PB, Lamagni T, Hope V. The HIV epidemic in injecting drug users.Commun Dis Rep 1997; 7: 128–30.
Bolumar F, Hernandez-Aguado I, Ferrer L. Prevalence of antibodies to hepatitis C in a population of intravenous drug users in Valencia, Spain, 1990–1992.Int J Epidemiol 1996; 25: 204–9.
Dorman A, Keenan E, Schuttler C et al. HIV risk behaviour in Irish intravenous drug users.Ir J Med Sci 1997; 166(4): 235–8.
Department of Health (Ireland) Government Strategy to Prevent Drug Misuse. May 1991.
Dean G, Kelly M, O’Hare A, Kelly G, O’Connor A. The opiate epidemic in Dublin 1978–1983.Ir Med J 1985; 78(4): 107–10.
Butler S. Drug problems and drug policies in Ireland. A quarter of a century review.Administration 1991; 39: 210–33.
Smyth BP, Keenan E, O’Connor JJ. Evaluation of the impact of Dublin’s expanded harm reduction programme on prevalence of hepatitis C amongst short-term injecting drug users with short term injecting histories.J Epidemiol Community Health 1999; 53: 434–5.
Cassin S, Geoghegan T. Young injectors: a comparative analysis of risk behaviour.Ir J Med Sci 1998; 167(4): 234–7.
Dean AG, Dean JA, Coulombicr D et al. Epi Info, Version 6; a word processing, database and statistics programme for epidemiology on microcomputers. Centers for Disease Control and Prevention, Atlanta, Georgia, USA, 1994.
Allwright S, Bradley F, Long J et al. Prevalence of antibodies to hepatitis B, hepatitis C and HIV and risk factors in Irish prisons: results of a national cross-sectoral survey.Br Med J 2000; 321: 78–82.
Stark K, Mueller R, Bienzle U. Frontloading: a risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin.AIDS 1996; 10: 311–7.
Crofts N, Campbell K. Incidence of blood-borne virus infection and risk behaviours in a cohort of injecting drug users in Victoria, 1990–1995.Med J Aust 1997; 167: 17–9.
Schwartlander B, Janssen RS, Satten G. Guidelines for designing rapid assessment surveys of HIV seroprevalence among hospitalised patients.Public Health Rep 1994; 109: 53–9.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fitzgerald, M., Barry, J., O’Sullivan, P. et al. Blood-borne infections in Dublin’s opiate users. Ir J Med Sci 170, 32–34 (2001). https://doi.org/10.1007/BF03167717
Issue Date:
DOI: https://doi.org/10.1007/BF03167717